Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Kobal, A
The FDA has approved various GLP-1 receptor agonists for different indications, including glycemic control in type 2 diabetes and chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Fatigue Some people experience fatigue during the first few weeks of tirzepatide use, regardless of dose
At Nexa Vitality, our providers are here to help you navigate these options and determine the best treatment plan for your needs
US$ 23.55
US$ 20.60
US$ 24.89
US$ 23.45
US$ 29.19
